CeifiT to distribute Revolutions RevVac safety syringe
CeifiT has entered into an agreement to distribute Revolutions Medical's RevVac auto-retractable vacuum safety syringe.
CeifiT gained distribution rights to distribute RevVac safety syringe in Israel, Jordan, the United Arab Emirates and Qatar, under the terms of agreement.
As per the exclusivity right, CeifiT should distribute a minimum of 3,000,000 units per quarter of the RevVac safety syringe.
The RevVac auto retractable vacuum safety syringe utilizes a patented technology in which a vacuum causes the needle to retract into the barrel of the syringe or device after an injection is administered or blood is drawn.
Revolutions Medical CEO and chairman Ron Wheet said RevVac safety syringe offers reductions of contaminated needles risks and also eliminates accidental needle sticks.
Related Insight
Suppliers Directory
Diagnostics In Vitro Diagnostics Diagnostic Imaging Endoscopy Devices
Patient Care Patient Monitoring Surgical & Supplies Wound Care Management
Technology Automation Healthcare IT Packaging
Contract Services
Certification
Drug Delivery Devices Intelligence
GlobalData’s new report, “External Defibrillators - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016” provides key data, information and analysis on the global external defibrillators market. The report provides market landscape, competitive landscape and market trends information the external defibrillators market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. Buy online from $3500
Comments may be moderated for spam, obscenities or defamation.